KELSEY STOKER: Open Payments
NPI 1114587847 · WELLFORD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 68 payments from 10 companies in 2025. Trend: 2023 $967 · 2024 $971 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $219 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $209 |
| Novo Nordisk Inc | 7 | $107 |
| Lilly USA, LLC | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 6 | $52 |
| Amgen Inc. | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Exact Sciences Corporation | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, Kerendia, Rybelsus, VOQUEZNA, OTEZLA, MOUNJARO, HETLIOZ, BREZTRI.
Industry payments across SC — which companies pay providers there.
